Cadrenal Therapeutics Inc (CVKD)
0.488
+0.02
(+4.95%)
USD |
NASDAQ |
May 03, 11:09
Cadrenal Therapeutics Total Assets (Quarterly): 8.519M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.519M |
| September 30, 2023 | 9.312M |
| June 30, 2023 | 3.559M |
| March 31, 2023 | 4.482M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.7782M |
| September 30, 2022 | 0.5453M |
| June 30, 2022 | 0.2433M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.2433M
Minimum
Jun 2022
9.312M
Maximum
Sep 2023
3.920M
Average
3.559M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Tenax Therapeutics Inc | 11.68M |
| Syra Health Corp | 4.923M |
| Relmada Therapeutics Inc | 97.55M |
| Minerva Neurosciences Inc | 56.90M |
| Adverum Biotechnologies Inc | 173.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.8269M |
| Shareholders Equity (Quarterly) | 7.692M |